Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Egenskap
Joint pain
Klinisk navn: Arthralgia
Joint pain.
Sammendrag
- Også kalt
- Joint pains, Arthralgias
- Kroppssystem
- Constitutional symptom
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
This page as data
Add .json to the page's address, or ask for application/json, to read it as JSON.
library(jsonlite)
url <- "https://dantelabs.com/traits/arthralgia.json"
page <- fromJSON(url)
page$trait$nameJoint painHP:0002829
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Les genene knyttet til Joint pain, og resten av genomet ditt, med én test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test202 gener knyttet til Joint pain
Endringer i disse genene forårsaker sjeldne tilstander der Joint pain forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Alltid | I 1 tilstand |
| ASAH1N-acylsphingosine amidohydrolase 1 | Alltid | I 2 tilstander |
| C1QBcomplement C1q B chain | Alltid | I 1 tilstand |
| CD81CD81 molecule | Alltid | I 1 tilstand |
| COL11A2collagen type XI alpha 2 chain | Alltid | I 3 tilstander |
| COL2A1collagen type II alpha 1 chain | Alltid | I 8 tilstander |
| FLNAfilamin A | Alltid | I 1 tilstand |
| GNB2G protein subunit beta 2 | Alltid | I 1 tilstand |
| GNPTGN-acetylglucosamine-1-phosphate transferase subunit gamma | Alltid | I 1 tilstand |
| IKZF2IKAROS family zinc finger 2 | Alltid | I 1 tilstand |
| IL36RNinterleukin 36 receptor antagonist | Alltid | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Alltid | I 2 tilstander |
| LBRlamin B receptor | Alltid | I 1 tilstand |
| LPIN2lipin 2 | Alltid | I 2 tilstander |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Alltid | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Alltid | I 7 tilstander |
| MMP2matrix metallopeptidase 2 | Alltid | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Alltid | I 6 tilstander |
| OTULINOTU deubiquitinase with linear linkage specificity | Alltid | I 1 tilstand |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Alltid | I 1 tilstand |
| PLCG2phospholipase C gamma 2 | Alltid | I 1 tilstand |
| POMPproteasome maturation protein | Alltid | I 1 tilstand |
| PSMB8proteasome 20S subunit beta 8 | Alltid | I 1 tilstand |
| SOSTsclerostin | Alltid | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Alltid | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Svært ofte (80–99 %) | I 1 tilstand |
| ANKHANKH inorganic pyrophosphate transport regulator | Svært ofte (80–99 %) | I 1 tilstand |
| ANTXR2ANTXR cell adhesion molecule 2 | Svært ofte (80–99 %) | I 1 tilstand |
| ATP7BATPase copper transporting beta | Svært ofte (80–99 %) | I 1 tilstand |
| CCN2cellular communication network factor 2 | Svært ofte (80–99 %) | I 2 tilstander |
| CD4CD4 molecule | Svært ofte (80–99 %) | I 1 tilstand |
| CHST3carbohydrate sulfotransferase 3 | Svært ofte (80–99 %) | I 2 tilstander |
| COL11A1collagen type XI alpha 1 chain | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 1 tilstand |
| DDB2damage specific DNA binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| ERCC5ERCC excision repair 5, endonuclease | Svært ofte (80–99 %) | I 1 tilstand |
| GLAgalactosidase alpha | Svært ofte (80–99 %) | I 1 tilstand |
Vis 162 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| GPR101G protein-coupled receptor 101 | Svært ofte (80–99 %) | I 2 tilstander |
| HGDhomogentisate 1,2-dioxygenase | Svært ofte (80–99 %) | I 2 tilstander |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 4 tilstander |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 3 tilstander |
| IL6interleukin 6 | Svært ofte (80–99 %) | I 1 tilstand |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| MFN2mitofusin 2 | Svært ofte (80–99 %) | I 1 tilstand |
| MIFmacrophage migration inhibitory factor | Svært ofte (80–99 %) | I 1 tilstand |
| MVKmevalonate kinase | Svært ofte (80–99 %) | I 3 tilstander |
| NLRP12NLR family pyrin domain containing 12 | Svært ofte (80–99 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Svært ofte (80–99 %) | I 2 tilstander |
| PLAAT3phospholipase A and acyltransferase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| PRTN3proteinase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| PTH1Rparathyroid hormone 1 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 3 tilstander |
| SEPTIN9septin 9 | Svært ofte (80–99 %) | I 1 tilstand |
| SLC26A2solute carrier family 26 member 2 | Svært ofte (80–99 %) | I 2 tilstander |
| TNFRSF11BTNF receptor superfamily member 11b | Svært ofte (80–99 %) | I 1 tilstand |
| TREM2triggering receptor expressed on myeloid cells 2 | Svært ofte (80–99 %) | I 2 tilstander |
| TYROBPtransmembrane immune signaling adaptor TYROBP | Svært ofte (80–99 %) | I 1 tilstand |
| VCPvalosin containing protein | Svært ofte (80–99 %) | I 1 tilstand |
| XPAXPA, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Svært ofte (80–99 %) | I 1 tilstand |
| ABCG5ATP binding cassette subfamily G member 5 | Ofte (30–79 %) | I 2 tilstander |
| ABCG8ATP binding cassette subfamily G member 8 | Ofte (30–79 %) | I 3 tilstander |
| ADA2adenosine deaminase 2 | Ofte (30–79 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Ofte (30–79 %) | I 1 tilstand |
| ARSBarylsulfatase B | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Ofte (30–79 %) | I 1 tilstand |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Ofte (30–79 %) | I 1 tilstand |
| C1Rcomplement C1r | Ofte (30–79 %) | I 1 tilstand |
| C1Scomplement C1s | Ofte (30–79 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CAV1caveolin 1 | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCN6cellular communication network factor 6 | Ofte (30–79 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| CCR6C-C motif chemokine receptor 6 | Ofte (30–79 %) | I 1 tilstand |
| CD247CD247 molecule | Ofte (30–79 %) | I 1 tilstand |
| CHST11carbohydrate sulfotransferase 11 | Ofte (30–79 %) | I 1 tilstand |
| CLIP2CAP-Gly domain containing linker protein 2 | Ofte (30–79 %) | I 1 tilstand |
| COL1A1collagen type I alpha 1 chain | Ofte (30–79 %) | I 2 tilstander |
| COL1A2collagen type I alpha 2 chain | Ofte (30–79 %) | I 1 tilstand |
| COL9A1collagen type IX alpha 1 chain | Ofte (30–79 %) | I 2 tilstander |
| COL9A2collagen type IX alpha 2 chain | Ofte (30–79 %) | I 1 tilstand |
| COL9A3collagen type IX alpha 3 chain | Ofte (30–79 %) | I 1 tilstand |
| COMPcartilage oligomeric matrix protein | Ofte (30–79 %) | I 2 tilstander |
| DDRGK1DDRGK domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Ofte (30–79 %) | I 1 tilstand |
| EIF4Heukaryotic translation initiation factor 4H | Ofte (30–79 %) | I 1 tilstand |
| ELNelastin | Ofte (30–79 %) | I 1 tilstand |
| EMILIN1elastin microfibril interfacer 1 | Ofte (30–79 %) | I 1 tilstand |
| EPORerythropoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Ofte (30–79 %) | I 1 tilstand |
| F8coagulation factor VIII | Ofte (30–79 %) | I 2 tilstander |
| FASFas cell surface death receptor | Ofte (30–79 %) | I 1 tilstand |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Ofte (30–79 %) | I 1 tilstand |
| GTF2Igeneral transcription factor IIi | Ofte (30–79 %) | I 1 tilstand |
| GTF2IRD1GTF2I repeat domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GTF2IRD2GTF2I repeat domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| HPGD15-hydroxyprostaglandin dehydrogenase | Ofte (30–79 %) | I 4 tilstander |
| IFNGR1interferon gamma receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| IL10interleukin 10 | Ofte (30–79 %) | I 2 tilstander |
| IL12Ainterleukin 12A | Ofte (30–79 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Ofte (30–79 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Ofte (30–79 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| IL2RBinterleukin 2 receptor subunit beta | Ofte (30–79 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| KIF7kinesin family member 7 | Ofte (30–79 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Ofte (30–79 %) | I 1 tilstand |
| LIMK1LIM domain kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| LOXL3lysyl oxidase like 3 | Ofte (30–79 %) | I 1 tilstand |
| METTL27methyltransferase like 27 | Ofte (30–79 %) | I 1 tilstand |
| NCF1neutrophil cytosolic factor 1 | Ofte (30–79 %) | I 1 tilstand |
| NLRC4NLR family CARD domain containing 4 | Ofte (30–79 %) | I 2 tilstander |
| NOTCH2notch receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| PHEXphosphate regulating endopeptidase X-linked | Ofte (30–79 %) | I 2 tilstander |
| PKDCCprotein kinase domain containing, cytoplasmic | Ofte (30–79 %) | I 1 tilstand |
| PLD4phospholipase D family member 4 | Ofte (30–79 %) | I 1 tilstand |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Ofte (30–79 %) | I 1 tilstand |
| PTPN6protein tyrosine phosphatase non-receptor type 6 | Ofte (30–79 %) | I 1 tilstand |
| RFC2replication factor C subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| RNU4ATACRNA, U4atac small nuclear | Ofte (30–79 %) | I 1 tilstand |
| RRAGDRas related GTP binding D | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Ofte (30–79 %) | I 1 tilstand |
| SMAD2SMAD family member 2 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstander |
| STAT4signal transducer and activator of transcription 4 | Ofte (30–79 %) | I 3 tilstander |
| STING1stimulator of interferon response cGAMP interactor 1 | Ofte (30–79 %) | I 1 tilstand |
| STX1Asyntaxin 1A | Ofte (30–79 %) | I 1 tilstand |
| TBL2transducin beta like 2 | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstander |
| TLR4toll like receptor 4 | Ofte (30–79 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Ofte (30–79 %) | I 1 tilstand |
| TMEM270transmembrane protein 270 | Ofte (30–79 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Ofte (30–79 %) | I 3 tilstander |
| TNXBtenascin XB | Ofte (30–79 %) | I 2 tilstander |
| TRAPPC2trafficking protein particle complex subunit 2 | Ofte (30–79 %) | I 2 tilstander |
| UBAC2UBA domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| VPS37DVPS37D subunit of ESCRT-I | Ofte (30–79 %) | I 1 tilstand |
| ABCC6ATP binding cassette subfamily C member 6 | Noen ganger (5–29 %) | I 1 tilstand |
| APCAPC regulator of Wnt signaling pathway | Noen ganger (5–29 %) | I 1 tilstand |
| APOBapolipoprotein B | Noen ganger (5–29 %) | I 1 tilstand |
| BCL11ABCL11 transcription factor A | Noen ganger (5–29 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Noen ganger (5–29 %) | I 2 tilstander |
| CD55CD55 molecule (Cromer blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| COL10A1collagen type X alpha 1 chain | Noen ganger (5–29 %) | I 1 tilstand |
| COL5A1collagen type V alpha 1 chain | Noen ganger (5–29 %) | I 1 tilstand |
| COL5A2collagen type V alpha 2 chain | Noen ganger (5–29 %) | I 1 tilstand |
| COPAcoat protein complex I subunit alpha | Noen ganger (5–29 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| FTLferritin light chain | Noen ganger (5–29 %) | I 1 tilstand |
| HBBhemoglobin subunit beta | Noen ganger (5–29 %) | I 3 tilstander |
| HBG1hemoglobin subunit gamma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HBG2hemoglobin subunit gamma 2 | Noen ganger (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Noen ganger (5–29 %) | I 1 tilstand |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IGKCimmunoglobulin kappa constant | Noen ganger (5–29 %) | I 1 tilstand |
| IL12Binterleukin 12B | Noen ganger (5–29 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| KLF1KLF transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| LDLRlow density lipoprotein receptor | Noen ganger (5–29 %) | I 1 tilstand |
| LDLRAP1low density lipoprotein receptor adaptor protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| LEMD3LEM domain containing 3 | Noen ganger (5–29 %) | I 1 tilstand |
| LMNAlamin A/C | Noen ganger (5–29 %) | I 1 tilstand |
| LMNB2lamin B2 | Noen ganger (5–29 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Noen ganger (5–29 %) | I 1 tilstand |
| MYH3myosin heavy chain 3 | Noen ganger (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PCSK9proprotein convertase subtilisin/kexin type 9 | Noen ganger (5–29 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SFRP4secreted frizzled related protein 4 | Noen ganger (5–29 %) | I 2 tilstander |
| SMPD1sphingomyelin phosphodiesterase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjelden (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjelden (1–4%) | I 2 tilstander |
| ASPNasporin | Ikke registrert | I 1 tilstand |
| CD244CD244 molecule | Ikke registrert | I 1 tilstand |
| CIITAclass II major histocompatibility complex transactivator | Ikke registrert | I 1 tilstand |
| DSEdermatan sulfate epimerase | Ikke registrert | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ikke registrert | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Ikke registrert | I 1 tilstand |
| IL1RNinterleukin 1 receptor antagonist | Ikke registrert | I 1 tilstand |
| MAFBMAF bZIP transcription factor B | Ikke registrert | I 1 tilstand |
| MATN3matrilin 3 | Ikke registrert | I 1 tilstand |
| MSMO1methylsterol monooxygenase 1 | Ikke registrert | I 1 tilstand |
| NFKBIL1NFKB inhibitor like 1 | Ikke registrert | I 1 tilstand |
| PSMB4proteasome 20S subunit beta 4 | Ikke registrert | I 1 tilstand |
| SLC22A4solute carrier family 22 member 4 | Ikke registrert | I 1 tilstand |
| SLC40A1solute carrier family 40 member 1 | Ikke registrert | I 1 tilstand |
| TRPS1transcriptional repressor GATA binding 1 | Ikke registrert | I 1 tilstand |
| UBA1ubiquitin like modifier activating enzyme 1 | Ikke registrert | I 1 tilstand |
| UFSP2UFM1 specific peptidase 2 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker